The international news story that broke at AIDS 2020, explained by the lead researcher.
This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect
Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.
Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.
Because the public is getting so many mixed messages, it’s our responsibility to provide clarity and moderate optimism.
Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies
Dr. Shahin Lockman says to not include women in trials is unethical.
Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.
Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.
Long-Acting Injectable HIV Meds Just as Good as Daily Pill for Newly Diagnosed and Those Already Undetectable
Questions still remain as to when FDA will approve, and how it will be implemented.
COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.
While the vaginal ring is still currently under FDA review, the new study will show whether it is safe and acceptable for people who are pregnant.